According to DelveInsight’s’ estimates, the adrenocortical carcinoma market in 7MM is expected to show positive growth, during the forecast period (2024–2034), mainly attributed to the anticipated launch of emerging therapies and the increasing cases of adrenocortical carcinoma. LAS…